产品展厅
搜索
公司首页
公司介绍
公司动态
产品展厅
证书荣誉
联系方式
在线留言
首页
>
产品展厅
Onartuzumab (anti-MET),1133766-06-9
Onartuzumab (anti-MET),1133766-06-9
Olokizumab (anti-IL-6),1007223-17-7
Olokizumab (anti-IL-6),1007223-17-7
Oleclumab (anti-CD73),1803176-05-7
Oleclumab (anti-CD73),1803176-05-7
Figitumumab (anti-IGF1R),943453-46-1
Figitumumab (anti-IGF1R),943453-46-1
Selicrelumab (anti-CD40),1622140-49-1
Selicrelumab (anti-CD40),1622140-49-1
Simtuzumab (anti-LOXL2),1318075-13-6
Simtuzumab (anti-LOXL2),1318075-13-6
Sotigalimab (anti-CD40),2305607-45-6
Sotigalimab (anti-CD40),2305607-45-6
Fezakinumab (anti-IL-22),1007106-86-6
Fezakinumab (anti-IL-22),1007106-86-6
Blosozumab (anti-SOST),1132758-87-2
Blosozumab (anti-SOST),1132758-87-2
Belantamab (anti-TNFRSF17),2061894-48-0
Belantamab (anti-TNFRSF17),2061894-48-0
Otelixizumab (anti-CD3),881191-44-2
Otelixizumab (anti-CD3),881191-44-2
Eptinezumab (anti-CGRP),1644539-04-7
Eptinezumab (anti-CGRP),1644539-04-7
Erenumab (anti-CALCRL),1582205-90-0
Erenumab (anti-CALCRL),1582205-90-0
Canakinumab (anti-IL-1b),914613-48-2
Canakinumab (anti-IL-1b),914613-48-2
Emicizumab (anti-Factor IX),1610943-06-0
Emicizumab (anti-Factor IX),1610943-06-0
Aprutumab (anti-FGFR2),1634620-63-5
Aprutumab (anti-FGFR2),1634620-63-5
第256页